paroxetine has been researched along with AIDS Dementia Complex in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haughey, N; McArthur, J; Mielke, MM; Moxley, R; Munro, C; Nath, A; Sacktor, N; Skolasky, RL; Steiner, J; Wang, S | 1 |
| Engle, EL; Graham, DR; Liu, J; Mankowski, JL; Meulendyke, KA; Nath, A; Queen, SE; Shirk, EN; Steiner, JP; Tarwater, PM; Zink, MC | 1 |
| Bachani, M; Haughey, NJ; Lee, MH; Li, G; Li, W; Nath, A; Steiner, JP; Strayer, D; Wang, T; Wolfson-Stofko, B | 1 |
1 trial(s) available for paroxetine and AIDS Dementia Complex
| Article | Year |
|---|---|
Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Drug Repositioning; Factor Analysis, Statistical; Female; Fluconazole; HIV-1; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Paroxetine; Patient Safety; Treatment Outcome | 2018 |
2 other study(ies) available for paroxetine and AIDS Dementia Complex
| Article | Year |
|---|---|
Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease.
Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Amyloid beta-Protein Precursor; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Fluconazole; Gene Expression; Humans; Macaca nemestrina; Neurofilament Proteins; Neurons; Nootropic Agents; Paroxetine; Primary Cell Culture; Rats; Selective Serotonin Reuptake Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load; Virus Replication | 2014 |
Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.
Topics: AIDS Dementia Complex; Animals; Blotting, Western; Cells, Cultured; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Knockout; Mitochondrial Proteins; Neuroprotective Agents; Paroxetine; Rats; Rats, Sprague-Dawley | 2015 |